Respiratory muscle dysfunction in long-COVID patients
暂无分享,去创建一个
L. Harbaum | M. Addo | H. Klose | S. Kluge | J. Schulze zur Wiesch | S. Schmiedel | J. K. Hennigs | J. Körbelin | T. Oqueka | M. Simon | Marie Huwe | A. Hennigs
[1] L. Harbaum,et al. [Organ-specific sequelae of COVID-19 in adults]. , 2022, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.
[2] H. Klose,et al. Organbezogene Folgeerscheinungen von COVID‑19 bei Erwachsenen , 2022, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.
[3] E. Wong,et al. Exertional intolerance and dyspnea with preserved lung function: an emerging long COVID phenotype? , 2021, Respiratory Research.
[4] David A. Drew,et al. Attributes and predictors of long COVID , 2021, Nature Medicine.
[5] Guohui Fan,et al. RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study , 2021, The Lancet.
[6] C. Ottenheijm,et al. Diaphragm Pathology in Critically Ill Patients With COVID-19 and Postmortem Findings From 3 Medical Centers. , 2020, JAMA internal medicine.
[7] Victor G. Puelles,et al. Multiorgan and Renal Tropism of SARS-CoV-2 , 2020, The New England journal of medicine.
[8] M. Endres,et al. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19 , 2020, European Respiratory Journal.
[9] M. Aepfelbacher,et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19 , 2020, Annals of Internal Medicine.
[10] M. Polkey,et al. ERS statement on respiratory muscle testing at rest and during exercise , 2019, European Respiratory Journal.
[11] P. Calverley,et al. American Thoracic Society Documents An Official American Thoracic Society Statement : Update on the Mechanisms , Assessment , and Management of Dyspnea , 2012 .
[12] W. Windisch,et al. [Respiratory muscle testing: state of the art]. , 2007, Pneumologie.